News Headlines Article

Sutter Health nabs another drug company research deal
Sacramento Business Journal

Sutter Health is teaming up with drug company giant Boehringer Ingelheim Pharmaceuticals Inc. on a five-year research partnership to collect data on patients with chronic lung disease, identify gaps in care and improve communication among providers about treatment options. The Connecticut-based U.S. subsidiary of the German drug company will work with Sutter doctors and researchers to test digital health programs and mobile technology — and analyze the data to learn how to improve care. No financial details were disclosed.